As described earlier in this article, mechanisms by which GBA1 mutations affect the severity of α-synucleinopathies severity occur through various molecular events, such as decreased GCase activity and disturbances in the MT GCase trafficking from the ER to the lysosome, which result in the accumulation of various products. This evidence concerns the gene GBA1 and synucleinopathy.